Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 182

Results For "ET"

10720 News Found

TB4 shows potential as a combination treatment for diabetes-induced complications of the cornea
Biotech | May 05, 2022

TB4 shows potential as a combination treatment for diabetes-induced complications of the cornea

The research was funded by the National Institutes of Health, the Eversight Center for Vision and Eye Banking Research, and Research to Prevent Blindness


Israeli researchers warn about the return of Delta variant
News | May 05, 2022

Israeli researchers warn about the return of Delta variant

The research was supported by the BGU Coronavirus Challenge and the Israeli Ministry of Health.


GOQii launches first of its kind one-stop solution for Diabetes care in India
Startup | May 04, 2022

GOQii launches first of its kind one-stop solution for Diabetes care in India

An Integrated programme comprising GOQii device, Glucometer – Contour Plus+1 from Ascensia Diabetes Care India and personalised diabetes coaching


HPRA completes audit of Biocon Biologics New mAbs drug substance facility
Biotech | May 04, 2022

HPRA completes audit of Biocon Biologics New mAbs drug substance facility

The inspection report contains no 'critical' observations and only one of the deficiencies is categorized as 'major' which is being addressed expeditiously in consultation with the regulatory agency


Eris Lifesciences acquires Oaknet Healthcare for Rs 650 crore
News | May 04, 2022

Eris Lifesciences acquires Oaknet Healthcare for Rs 650 crore

The deal will be financed by Rs 300 crore of internal accruals and Rs 350 crore of borrowings


Juniper Biologics signs exclusive license agreement with Helsinn for infigratinib (INN) for the emerging markets including India
Biotech | May 04, 2022

Juniper Biologics signs exclusive license agreement with Helsinn for infigratinib (INN) for the emerging markets including India

Infigratinib is not FDA-, Health Canada- or Therapeutics Goods Association-approved for any other indication


Gland launches Bortezomib in the US market
Drug Approval | May 04, 2022

Gland launches Bortezomib in the US market

Bortezomib for injection is used to treat certain types of cancer such as multiple myeloma and mantle cell lymphoma


Pfizer sets up global drug development centre in Chennai
News | May 04, 2022

Pfizer sets up global drug development centre in Chennai

The facility is among 12 centres established worldwide, and the first in Asia


Dr. Mansukh Mandaviya to chair a three-day health meet at Kevadia in Gujarat
News | May 02, 2022

Dr. Mansukh Mandaviya to chair a three-day health meet at Kevadia in Gujarat

State Ministers of Health and Medical Education to Participate in the meeting from 5th to 7th May


World’s first AI software for detecting pancreatic disease on the horizon
Biotech | May 02, 2022

World’s first AI software for detecting pancreatic disease on the horizon

As an industrial partner of the IHU, the Medi-Globe Group is thus further expanding its role as an innovation leader in minimally invasive diagnostics and therapies